Objective: To determine the inter-relationships between five first trimester biomarkers (pregnancy associated plasma protein A [PAPP-A], alpha-fetoprotein [AFP], beta human chorionic gonadotrophin [beta-hCG], placenta growth factor [PlGF] and soluble fms-like tyrosine kinase receptor-1 [sFlt-1]) and a range of adverse pregnancy outcomes (APOs). Design: Prospective cohort study of nulliparous singleton pregnancy. Setting: Cambridge, UK. Population or Sample: 4056 Pregnancy Outcome Prediction study participants. Methods: The biomarker concentrations were measured in maternal serum at ~12 weeks of gestation. Univariable analysis of APOs was performed using logistic regression. Multivariable analysis used best subsets logistic regression with...
Background: Estimation of serum PAPP-A levels studied predictability for adverse perinatal outcome. ...
Objective: To assess the ability of first trimester maternal serum (FTMS) soluble Fms-like tyrosine ...
Background: Serum pregnancy-associated plasma protein-A (PAPP-A) levels fluctuate in continuation wi...
Objective: To determine the inter-relationships between five first trimester biomarkers (pregnancy a...
INTRODUCTION: Low maternal serum levels of pregnancy-associated plasma protein A (PAPP-A) measured i...
Background The NICHD Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be (nuMoM2b) was e...
Background To determine the association between extreme values of first trimester markers and advers...
Objective: The study aimed to investigate the association between placental growth factor (PlGF) and...
Introduction: Abnormal levels of first trimester placental biomarkers are associated with the develo...
Placental dysfunction is implicated in many major complications of pregnancy associated with adverse...
Adverse pregnancy outcomes such as preterm delivery, hypertensive disorders of pregnancy, small for ...
AbstractPlacental dysfunction is implicated in many major complications of pregnancy associated with...
To determine the clinical relevance of maternal characteristics and first-trimester serum concentrat...
OBJECTIVE: Are first trimester serum pregnancy-associated plasma protein-A (PAPP-A), nuchal transluc...
STUDY QUESTION Are novel circulating placental markers prokineticin-1 (PK-1), soluble fms-like tyros...
Background: Estimation of serum PAPP-A levels studied predictability for adverse perinatal outcome. ...
Objective: To assess the ability of first trimester maternal serum (FTMS) soluble Fms-like tyrosine ...
Background: Serum pregnancy-associated plasma protein-A (PAPP-A) levels fluctuate in continuation wi...
Objective: To determine the inter-relationships between five first trimester biomarkers (pregnancy a...
INTRODUCTION: Low maternal serum levels of pregnancy-associated plasma protein A (PAPP-A) measured i...
Background The NICHD Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be (nuMoM2b) was e...
Background To determine the association between extreme values of first trimester markers and advers...
Objective: The study aimed to investigate the association between placental growth factor (PlGF) and...
Introduction: Abnormal levels of first trimester placental biomarkers are associated with the develo...
Placental dysfunction is implicated in many major complications of pregnancy associated with adverse...
Adverse pregnancy outcomes such as preterm delivery, hypertensive disorders of pregnancy, small for ...
AbstractPlacental dysfunction is implicated in many major complications of pregnancy associated with...
To determine the clinical relevance of maternal characteristics and first-trimester serum concentrat...
OBJECTIVE: Are first trimester serum pregnancy-associated plasma protein-A (PAPP-A), nuchal transluc...
STUDY QUESTION Are novel circulating placental markers prokineticin-1 (PK-1), soluble fms-like tyros...
Background: Estimation of serum PAPP-A levels studied predictability for adverse perinatal outcome. ...
Objective: To assess the ability of first trimester maternal serum (FTMS) soluble Fms-like tyrosine ...
Background: Serum pregnancy-associated plasma protein-A (PAPP-A) levels fluctuate in continuation wi...